Infectious Diseases Related Content

Researchers from the University of Liverpool and King’s College London have received a £2.3 million fund from UK Research and Innovation (UKRI) to investigate the neurological impacts of COVID-19.

Professor Martin Michaelis and Dr Mark Wass of University of Kent’s School of Biosciences, explain why a herd immunity approach to COVID-19 would include great risk, potentially many deaths, and may simply not work.

Richard J. C. Brown, Head of Metrology and Jan-Theodoor Janssen, Chief Scientist from the National Physical Laboratory, Teddington, explore why the system doesn’t work if everyone is measuring COVID-related deaths differently and how a standardised international definition of COVID-related deaths could bolster public trust.

A recent survey conducted by Solopress, reveals that 66% of hospitality employees want COVID-19 rules in their workplace to remain permanent .

Sébastien Paris, founder and CEO of ONHYS, explores how crowd simulation could be the key to mitigating the disruption caused by COVID-19.

The Urban Waste Water Treatment Directive (UWWTD) has shown an overall improvement in collection and treatment of wastewater in Europe's cities and towns.

A new study combines genomics from COVID-19 samples with computer-simulated epidemics and travel records to reconstruct the virus' spread across the world.

A new study has revealed that COVID-19 antibodies fade after only a month, which could be a devastating blow in the global race to find a vaccine.

A new study shows travelling from the home is associated with significantly higher likelihood of contracting COVID-19, while strict social distancing prevents infection.

Researchers have discovered that COVID-19 patients recover faster the sooner they undergo rehabilitation after leaving intensive care.

Two divisions of Active Care Group – Christchurch Group and Remeo – discuss the importance of  infection prevention and control in the healthcare sector in light of COVID-19.

Russia is the first country to announce the approval of a COVID-19 vaccine, without completing clinical trials.

A new study led by Children's National Hospital researchers shows that minority and socioeconomically disadvantaged children have significantly higher rates of COVID-19 infection.

Paul De Raeve, Secretary General and Elisabeth Adams, President of the European Federation of Nurses Associations state the case for being better prepared for the next health crisis in the European Union in light of COVID-19.

Scientists from the University of Oxford, joint with AstraZeneca, are hopeful that their vaccine, to protect against Covid-19, could be available as early as September.

EIB and CureVac have signed a €75m loan agreement to develop a large-scale production of vaccines, including CureVac's vaccine candidate against SARS-CoV-2.

Gerald Misinzo and Mark Rweyemamu from SACIDS Foundation for One Health provide a detailed look at one health research by the Africa centres of excellence for infectious diseases of humans and animals.

Here, experts Stephan Pleschka, Oliver Planz and Stephan Ludwig walk us through the constant threat of influenza virus outbreaks and the benefit of enduring research in antiviral drug development.

Professor Behzad Samii, professor of operations and supply chain management at Vlerick Business School, discusses how to fairly circulate a COVID-19 vaccine.

Jane Kinghorn, Director at UCL Translational Research Office and Nick McNally, Managing Director Research UCL/UCLH, describe some of the approaches taken by the scientific community in supporting hospitals dealing with the COVID-19 pandemic.